Cure Research: CROI 2018
Fast Look
Cure research highlights from CROI 2018
by Jeannie Wraight
The Conference on Retroviruses and Opportunistic Infections (CROI) provides an annual snapshot of the year’s most...
Questioning the Cure
When first discussing the potential of writing a monthly column on HIV cure, my editor here at A&U Magazine asked a very valid question....
Imbokodo Study Launches
The Strength of Women
The Imbokodo Study launches in Southern Africa
by Jeannie Wraight
In Zulu, the word “Imbokodo” means “rock” and is part of a well-known...
Why We Need a Vaccine
As with any viral outbreak, the two main goals from Day One of the known HIV epidemic/pandemic have been controlling the spread of the...
Novel Cure Research Supported by amfAR
Deciphering the Puzzle
A new round of amfAR's Countdown to a Cure initiative grants support novel cure research
by Jeannie Wraight
amfAR has awarded a new round...
ABX 464 Aims to Reduce HIV Reservoirs
Revving Up
Investigational agent ABX 464 seeks to reduce HIV reservoirs
by Jeannie Wraight
ABX 464 is making its way through clinical trials, showing strong potential as...
PaxVax’s Vaccine Platform & Other Research Build Momentum
Gaining Momentum
HIV vaccine candidates seek to make good on their early promise
by Jeannie Wraight and David Miller
Over the past several years, momentum for the...
IV Drug Users & HIV Vaccine Response
Everyone Counts
Differences in intravenous drug users may affect their response to an HIV vaccine
by Jeannie Wraight
Prevention strategies such as Treatment as Prevention, PrEP, syringe...
HIV Remission Studies & Starting ARVs Early
Step by Step
At CROI 2017, HIV remission studies focus on early antiretroviral therapy initiation
by Jeannie Wraight
This year marked the 24th annual Conference on Retroviruses...
The New Administration & the Threat to HIV Care and Cure...
Buyer Beware
The new administration may threaten HIV care and cure research
by Jeannie Wraight
Our way of life in the U.S. has already drastically changed as...